• A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Linagliptin

Linagliptin | CAS NO: 668270-12-0 Linagliptin is primarily used for the management of type 2 diabetes mellitus. Blood Sugar Control: Linagliptin helps lower blood glucose levels by increasing insulin secretion and decreasing glucagon levels in response to meals. Combination Therapy: Linagliptin can be combined with other diabetes medications, such as metformin or insulin, to improve glycemic control. Always consult a healthcare professional for personalized medical advice and treatment options.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Linagliptin impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities It can be used alone when diet and exercise are not enough to control blood sugar.Type 2 Diabetes Management: To improve blood sugar control in adults with type 2 diabetes. Monotherapy: As a standalone treatment when diet and exercise alone are insufficient. Combination Therapy: Used alongside other diabetes medications (like metformin or insulin) to enhance glycemic control. we the Synchemia are ensuring the purity and quality of its impurities which is crucial for pharmaceutical API manufacturing companies for regulatory compliance. Buy Reliable and High-Purity Linagliptin Impurities, Delivered by Synchemia Research Chemicals.

Pharmaceutical Reference Standards

Linagliptin

CAT No : SRC-L12001

CAS No: 668270-12-0

Mol.F.: C25H28N8O2

Mol.Wt.: 472.6 g/mol

Inv. Status: Custom Synthesis

Linagliptin Impurity B

CAT No : SRC-L12002

CAS No: 2138392-83-1

Mol.F.: C26H21BrN8O2

Mol.Wt.: 557.4 g/mol

Inv. Status: Custom Synthesis

Linagliptin Impurity D

CAT No : SRC-L12003

CAS No: NA

Mol.F.: C20H18N6O3

Mol.Wt.: 390.4 g/mol

Inv. Status: Custom Synthesis

Linagliptin Impurity F

CAT No : SRC-L12004

CAS No: NA

Mol.F.: C19H26N4O2

Mol.Wt.: 342.4 g/mol

Inv. Status: Custom Synthesis

Linagliptin Impurity G

CAT No : SRC-L12005

CAS No: NA

Mol.F.: C36H40N10O4

Mol.Wt.: 676.8 g/mol

Inv. Status: Custom Synthesis

Linagliptin Impurity M

CAT No : SRC-L12006

CAS No: NA

Mol.F.: C15H20N4

Mol.Wt.: 256.4 g/mol

Inv. Status: Custom Synthesis

Linagliptin Impurity N

CAT No : SRC-L12007

CAS No: NA

Mol.F.: C31H32N10O2

Mol.Wt.: 576.7 g/mol

Inv. Status: Custom Synthesis

Linagliptin Impurity S

CAT No : SRC-L12008

CAS No: 1638744-06-5

Mol.F.: C25H29BrN8O2

Mol.Wt.: 553.5 g/mol

Inv. Status: Custom Synthesis

Linagliptin Related Compound A

CAT No : SRC-L12009

CAS No: 666816-98-4

Mol.F.: C10H9BrN4O2

Mol.Wt.: 297.1 g/mol

Inv. Status: Custom Synthesis

Linagliptin Related Compound B

CAT No : SRC-L12010

CAS No: 668273-75-4

Mol.F.: C30H36N8O4

Mol.Wt.: 572.7 g/mol

Inv. Status: Custom Synthesis